The Importance of Clinical Data for the Medical Cannabis Industry
FREMONT, CA – Over the last few years, the clinical data regarding medical cannabis research has burgeoned, necessitating the development of robust systems to analyze critical information. The obstacles hindering the study have been swept aside with the legalization of cannabis consumption for medical and recreational purposes in numerous states across the U.S.
For many years, most of the cannabis-based research was conducted in Israel, and later on, in Canada. The emergence of new markets has sparked new potential for cannabis research. However, accurate data regarding cannabis is required by researchers, physicians, and other stakeholders. In this regard, many organizations in the cannabis sector are collaborating with data technology companies to develop data systems. The cannabis-based systems will aid medical professionals and researchers to keep track of the relevant information.
Check This Out: Top Clinical Data Management Companies
With the opioid crisis plaguing the world of medicine, many organizations are turning toward cannabis as a potential replacement. Several states, including New York, Pennsylvania, and New Jersey are allowing the use of cannabis for pain treatments. Since the successful use of cannabis-based treatment on children suffering from epileptic disorders, many medical organizations are delving into the troves of clinical data to determine the effectiveness of cannabis treatments for different conditions.
The increase in demand for medical cannabis, even among the patients, is driving the growth of the industry. By the year 2023, the global medical cannabis industry is expected to rise to $37 billion at a rate of 22 percent from $11 billion in the year 2017. According to a survey conducted among the clinics, there is an increase in the number of customers inquiring about medical cannabis. Hence, it is imperative that medical institutions have access to accurate clinical information regarding cannabis.
Researchers have come a long way in narrowing the gap in the medical knowledge created by the legal barriers regarding the use of cannabis. The emergence of data solutions has enabled medical professionals to gather a vast amount of information to aid in their treatments. As the research progresses, medical professionals will need focused access to specific information to bolster their medical decisions.
By Tom Conophy, CIO, Staples Inc.
By Joe Touey, SVP, GSK North America Pharmaceuticals IT
By Eric Tamblyn, Global VP-Guru Managed Services, Genesys
By Charlie Isaacs, CTO, IoT, Salesforce
By Jonathan Rosenberg, VP & CTO, Collaboration, Cisco
By Dave Doyle, CIO & SVP, IT, Regal Entertainment Group
By Jeffrey Keisling, CIO and SVP, Pfizer
By Colin Boyd, VP & CIO, Joy Global Inc
By George Hines, CIO, Massage Envy
By Mark Jacobsohn, SVP, Booz Allen Hamilton
By Mike Gioja, CIO and SVP of IT, Product Management and...
By Nathan Johnson, SVP and CIO, Werner Enterprises [NASDAQ:...
By Darrell Edwards, SVP and Chief Supply Chain Officer,...
By Hannah Datz, VP Retail North America, SAP Hybris
By Marc Kermisch, VP & CIO, Red Wing Shoe Co.
By Robert Garrison, CIO, DTCC
By Mike Sakamoto, CTO, California Department of Health Care...
By Bradley Peterson, EVP & CIO, NASDAQ
By Steve Betts, SVP and CIO, Blue Cross and Blue Shield and...
By Kathryn Kai-ling (Ho) Frederick, EVP, Growth & Insights,...